MedTrace Logo

Blended Unified Protocol for Emotional Disorders in Primary Care

NCT07432906 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2026-02-25

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a "blended" therapy format (combining face-to-face therapy sessions with a smartphone app) works to treat emotional disorders, such as depression and anxiety, in adults. It will also see if this blended format is feasible and acceptable for patients in primary care settings.

The main questions it aims to answer are:

Does the blended therapy format reduce symptoms of depression and anxiety?

Is the blended format as effective as standard face-to-face therapy?

Do participants find the smartphone app easy and helpful to use?

Researchers will compare the blended therapy group to a standard face-to-face therapy group and a wait-list control group to see if the blended approach works well.

Participants will:

Attend therapy sessions based on the Unified Protocol (a type of cognitive-behavioral therapy) for about 10 weeks.

Use a smartphone app to complete exercises and track their emotions (if assigned to the blended group).

Answer questionnaires about their symptoms and quality of life at the beginning, at the end of treatment, and 3 months later.

Conditions

Interventions

BEHAVIORAL

Unified Protocol

A transdiagnostic cognitive-behavioral intervention consisting of 8 modules targeting emotion regulation mechanisms. It includes psychoeducation, mindful emotion awareness, cognitive flexibility, countering emotional behaviors, and exposure exercises.

Sponsors & Collaborators

  • Aydin Adnan Menderes University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-28
Primary Completion
2026-08-31
Completion
2026-10-31

Countries

  • Turkey (Türkiye)

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07432906 on ClinicalTrials.gov